Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 24/6/2019
SIETES contiene 92761 citas

 
 
 1 a 20 de 35 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Harding BN, Weiss NS, Walker RL, Larson EB, Dublin S. Proton pump inhibitor use and the risk of fractures among an older adult cohort. Pharmacoepidemiol Drug Saf 2018;27:junio. [Ref.ID 102801]
2.Enlace a cita original Cita con resumen
Gray SL, Walker RL, Dublin S, Yu O, Aielo Bowles EJ, Anderson ML, Crane PK, Larson EB. Proton pump inhibitor use and dementia risk: prospective population-based study. J Am Geriatr Soc 2018;66:febrero. [Ref.ID 102537]
3. Cita con resumen
Gray SL, Dublin S, Yu O, Walker R, Anderson M, Hubbard RA, Crane PK, Larson EB. Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study. BMJ 2016;352:i90. [Ref.ID 100037]
4.Tiene citas relacionadas Cita con resumen
Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, Yu O, Krane PK, Larson EB. Cumulative use of strong anticholinergics and incident dementia. A prospective cohort study. JAMA Intern Med 2015;175:401-7. [Ref.ID 98842]
5. Cita con resumen
Boudreau DM, Yu O, Gray SL, Raebel MA, Johnson J, Larson EB. Concomitant use of cholinesterase inhibitors and anticholinergics: prevalence and outcomes. J Am Geriatr Soc 2011;59:2069-76. [Ref.ID 91576]
6. Cita con resumen
Boger-Megiddo I, Heckbert SR, Weiss NS, McKnight B, Furberg CD, Wiggins KL, Delaney JAC, Siscovick DS, Larson EB, Lemaitre RN, Smith NL, Rice KM, Glazer NL, Psaty BM. Myocardial infarction and stroke associated with diuretic based two drug antihypertensive regimens: population based case-control study. BMJ 2010;340:303. [Ref.ID 87762]
7. Cita con resumen
Dublin S, Jackson ML, Nelson JC, Weiss NS, Larson EB, Jackson LA. Statin use and risk of community acquired pneumonia in older people: population based case-control study. BMJ 2009;338:1486. [Ref.ID 86087]
8.Tiene citas relacionadas Cita con resumen
O'Hare AM, Kaufman JS, Covinsky KE, Landefeld CS, McFarland LV, Larson EB. Current guidelines for using angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease: is the evidence base relevant to older adults?. Ann Intern Med 2009;150:717-24. [Ref.ID 85908]
9.Enlace a cita original Cita con resumen
Breitner JCS, Haneuse JPA, Walker R, Dublin S, Crane PK, Gray SL, Larson EB. Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort. Neurology 2009;72:1519-25. [Ref.ID 85671]
10. Cita con resumen
Williams RL, Johnson SB, Greene SM, Larson EB, Green LA, Morris A, Confer D, Reaman G, Madigan R, Kahn J, for the Principal Investigators of the Clinical Research Networks Initiative. Signposts along the NIH roadmap for reengineering clinical research. Lessons from the Clinical Research Networks initiative. Arch Intern Med 2008;168:1919-25. [Ref.ID 84105]
11.Tiene citas relacionadas
Larson EB. Physical activity for older adults at risk for Alzheimer disease. JAMA 2008;300:1077-9. [Ref.ID 83909]
12.Tiene citas relacionadas
Larson EB, Langa KM. The rising tide of dementia worldwide. Lancet 2008;372:430-2. [Ref.ID 83755]
13.
Gallagher TH, Garbutt JM, Waterman AD, Flum DR, Larson EB, Waterman BM, Flum DR, Waterman BM, Dunagan WC, Fraser VJ, Levinson W. Choosing your words carefully. How physicians would disclose harmful medical errors to patients. Arch Intern Med 2006;166:1585-93. [Ref.ID 77904]
14. Cita con resumen
Lemaitre RN, Weiss NS, Smith NL, Psaty BM, Lumley T, Larson EB, Heckbert SR. Esterified estrogen and conjugated equine estrogen and the risk of incident myocardial infarction and stroke. Arch Intern Med 2006;166:399-404. [Ref.ID 76258]
15.
Langa KM, Foster NL, Larson EB. Mixed dementia. Emerging concepts and therapeutic implications. JAMA 2004;292:2901-8. [Ref.ID 72098]
16.Tiene citas relacionadas Cita con resumen
Smith NL, Heckbert SR, Lemaitre RN, Reiner A P, Lumley T, Weiss NS, Larson EB, Rosendaal F R, Psaty B M. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. JAMA 2004;292:1581-7. [Ref.ID 71587]
17.Tiene citas relacionadas Cita con resumen
Larson EB, Shadlen MF, Wang L, McCormick WC, Bowen JD, Teri L, Kukull WA. Survival after initial diagnosis of Alzheimer disease. Ann Intern Med 2004;140:501-9. [Ref.ID 69755]
18.
Teri L, Gibbons LE, McCurry SM, Logsdon RG, Buchner DM, Barlow WE, Kukull WA, LaCroix AZ, McCormick W, Larson EB. Exercise plus behavioral management in patients with Alzheimer disease. A randomized controlled trial. JAMA 2003;290:2015-22. [Ref.ID 67834]
19.
Sheffield JVL, Larson EB. Update in general internal medicine. Ann Intern Med 2001;135:269-78. [Ref.ID 58419]
20.
Gray SL, Lai KV, Larson EB. Drug-induced cognition disorders in the elderly: incidence, prevention and management. Drug Saf 1999;21:101-22. [Ref.ID 46033]
Seleccionar todas
 
 1 a 20 de 35 siguiente >>